RE:RE:RE:Voting Incompetent Management Out The facts are the facts despite missed guidance.
400% return on the stock since she took over the Company.
100% return in the last two years
There have been swings up to over $1.00 and $2.00 but
the only verbal trend has been up with frequent pullbacks and then Higher lows.
Sales grown from 0 to $10 million with out significant increase in cash expenses
Close to target margins of 75% even with a high percentage of sales from lower margin devices
Over 90% reduction in losses in the last year from a $4 million loss to $122k. There is no doubt the Company will be profitable in 2023
Huge patient pipeline that is close if not over 1 million patient and could be worth over $500 million in sales.
Collections are slow and may be an issue at some point but both Reliq and their Auditors believe there is a high likely hood of collection based on the financials.
In 2023 the down side of a profitable Company with $10 million in revenue is $0.50 a share and the upside is a Company with over $100 million in revenue and 43% EBITA margin which is $10 a share. This is a no brainer continued investment for me.